DP4/DP6 (GKG/LED) was significant in non-BCP leukaemia after correction (OR, CI: 2.7, 1.6–4.9; P=0.002), but not in BCP ALL or solid tumours. This evidence concerns the gene TFDP3 and acute lymphoblastic leukemia.